Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria

Background: Adherence to antimalarial drug regimens is improved by simple dosing. If the fixed antimalarial drug combination artemether-lumefantrine (AL) could be given once daily, this should improve adherence and thus effectiveness and lower the risk of selecting for resistance. Methods: In an ope...

Full description

Saved in:
Bibliographic Details
Main Authors: Elizabeth A. Ashley, Kasia Stepniewska, Niklas Lindegårdh, Rose McGready, Anna Annerberg, Robert Hutagalung, Thida Singtoroj, Gilvary Hla, Al Brockman, Stephane Proux, Jahser Wilahphaingern, Pratap Singhasivanon, Nicholas J. White, François Nosten
Other Authors: Shoklo Malaria Research Unit
Format: Article
Published: 2018
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/24589
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University
id th-mahidol.24589
record_format dspace
spelling th-mahidol.245892018-08-24T09:10:42Z Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria Elizabeth A. Ashley Kasia Stepniewska Niklas Lindegårdh Rose McGready Anna Annerberg Robert Hutagalung Thida Singtoroj Gilvary Hla Al Brockman Stephane Proux Jahser Wilahphaingern Pratap Singhasivanon Nicholas J. White François Nosten Shoklo Malaria Research Unit Mahidol University Churchill Hospital Menzies School of Health Research Immunology and Microbiology Medicine Background: Adherence to antimalarial drug regimens is improved by simple dosing. If the fixed antimalarial drug combination artemether-lumefantrine (AL) could be given once daily, this should improve adherence and thus effectiveness and lower the risk of selecting for resistance. Methods: In an open randomized study, 43 patients with uncomplicated falciparum malaria were given equivalent doses of AL with 200 ml flavoured milk either as the conventional twice-daily regimen or as a single daily dose for 3 days. The primary end point was a comparison of the areas under the plasma lumefantrine concentration-time curves (AUC). Secondary end points were the day 42 polymerase chain reaction (PCR)-adjusted cure rates and the tolerability profiles. Results: Lumefantrine pharmacokinetic profiles were obtained for 36 patients. The AUC(0→∞)of the once-daily regimen was 30% lower than that in the conventional regimen (P = 0.011) with a median (range) value of 306 (114-5781) μg/ml h, compared with 432 (308-992) μg/ml h. There was no significant difference in the peak plasma concentrations reached. PCR-adjusted cure rate estimates at day 42 of follow-up were 94% (95% CI: 84-100) in the six-dose arm and 85% (70-100) in the three-dose arm (P = 0.3). Conclusion: Artemether-lumefantrine efficacy is reduced by once-daily dosing, because absorption of lumefantrine is dose limited. At currently recommended doses, this antimalarial should be given twice daily in a 3-day regimen, with food containing fat. © 2007 Blackwell Publishing Ltd. 2018-08-24T01:54:39Z 2018-08-24T01:54:39Z 2007-02-01 Article Tropical Medicine and International Health. Vol.12, No.2 (2007), 201-208 10.1111/j.1365-3156.2006.01785.x 13653156 13602276 2-s2.0-33846952552 https://repository.li.mahidol.ac.th/handle/123456789/24589 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33846952552&origin=inward
institution Mahidol University
building Mahidol University Library
continent Asia
country Thailand
Thailand
content_provider Mahidol University Library
collection Mahidol University Institutional Repository
topic Immunology and Microbiology
Medicine
spellingShingle Immunology and Microbiology
Medicine
Elizabeth A. Ashley
Kasia Stepniewska
Niklas Lindegårdh
Rose McGready
Anna Annerberg
Robert Hutagalung
Thida Singtoroj
Gilvary Hla
Al Brockman
Stephane Proux
Jahser Wilahphaingern
Pratap Singhasivanon
Nicholas J. White
François Nosten
Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria
description Background: Adherence to antimalarial drug regimens is improved by simple dosing. If the fixed antimalarial drug combination artemether-lumefantrine (AL) could be given once daily, this should improve adherence and thus effectiveness and lower the risk of selecting for resistance. Methods: In an open randomized study, 43 patients with uncomplicated falciparum malaria were given equivalent doses of AL with 200 ml flavoured milk either as the conventional twice-daily regimen or as a single daily dose for 3 days. The primary end point was a comparison of the areas under the plasma lumefantrine concentration-time curves (AUC). Secondary end points were the day 42 polymerase chain reaction (PCR)-adjusted cure rates and the tolerability profiles. Results: Lumefantrine pharmacokinetic profiles were obtained for 36 patients. The AUC(0→∞)of the once-daily regimen was 30% lower than that in the conventional regimen (P = 0.011) with a median (range) value of 306 (114-5781) μg/ml h, compared with 432 (308-992) μg/ml h. There was no significant difference in the peak plasma concentrations reached. PCR-adjusted cure rate estimates at day 42 of follow-up were 94% (95% CI: 84-100) in the six-dose arm and 85% (70-100) in the three-dose arm (P = 0.3). Conclusion: Artemether-lumefantrine efficacy is reduced by once-daily dosing, because absorption of lumefantrine is dose limited. At currently recommended doses, this antimalarial should be given twice daily in a 3-day regimen, with food containing fat. © 2007 Blackwell Publishing Ltd.
author2 Shoklo Malaria Research Unit
author_facet Shoklo Malaria Research Unit
Elizabeth A. Ashley
Kasia Stepniewska
Niklas Lindegårdh
Rose McGready
Anna Annerberg
Robert Hutagalung
Thida Singtoroj
Gilvary Hla
Al Brockman
Stephane Proux
Jahser Wilahphaingern
Pratap Singhasivanon
Nicholas J. White
François Nosten
format Article
author Elizabeth A. Ashley
Kasia Stepniewska
Niklas Lindegårdh
Rose McGready
Anna Annerberg
Robert Hutagalung
Thida Singtoroj
Gilvary Hla
Al Brockman
Stephane Proux
Jahser Wilahphaingern
Pratap Singhasivanon
Nicholas J. White
François Nosten
author_sort Elizabeth A. Ashley
title Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria
title_short Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria
title_full Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria
title_fullStr Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria
title_full_unstemmed Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria
title_sort pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria
publishDate 2018
url https://repository.li.mahidol.ac.th/handle/123456789/24589
_version_ 1763491474784124928